Patent details

Basic Information

Publication number:

EP2392572

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP111776928

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Substituted diazepan compounds as orexin receptor antagonists

French Title of Invention:

Antagonistes des récepteurs de l'orexine sous forme de composés de diazépane substitués

German Title of Invention:

Substituierte Diazepanverbindungen als Orexin-Rezeptor-Antagonisten

SPC Number:

Dates

Filing date:

30/11/2007

Grant date:

14/05/2014

EP Publication Date:

14/05/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/12/2011

EP B1 Publication Date:

14/05/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

30/11/2014

Expiration date:

30/11/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

30/11/2007

 

 

Name:

Merck Sharp & Dohme Corp.

Address:

126 East Lincoln Avenue, Rahway, NJ 07065-0907, United States (US)

Inventor

1

Name:

Cox Christopher, D.

Address:

United States (US)

2

Name:

Mercer Swati, P.

Address:

United States (US)

3

Name:

Coleman Paul, J.

Address:

United States (US)

4

Name:

Roecker Anthony, J.

Address:

United States (US)

5

Name:

Breslin Michael, J.

Address:

United States (US)

6

Name:

Bergman Jeffrey, M.

Address:

United States (US)

Priority

1

Priority Number:

872393 P

Priority Date:

01/12/2006

Priority Country:

United States (US)

2

Priority Number:

959742 P

Priority Date:

16/07/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 401/14;

Filing date	Document type	Number of pages